A Universal Shield Against All COVID-19 Variants
Researchers at the University of Helsinki have developed TriSb92, a molecule that can effectively prevent infection from all known SARS-CoV-2 variants when administered nasally. The molecule targets a common region in the virus’s spike protein and inhibits its functioning. Experiments on cell cultures and animal models have shown its efficacy against even the latest variants, … Read more